Growing preference for drugs enclosed in capsules among consumers, pharmaceutical manufacturers, and nutraceutical manufacturers is set to propel the market
PORTLAND, OR, UNITED STATES, October 30, 2020 /EINPresswire.com/ — UPDATE AVAILABLE ON-DEMAND
The report on the global empty capsules market highlights that the market is expected to reach $1,841.5 million by 2017, from $3,707.5 million in 2025, growing at a CAGR of 9.1% from 2018 to 2025. The report offers the current market size and forecasts along with Porter’s Five Forces analysis to help market players, stakeholders, startups, and investors to determine the current scenario and take further steps for the future. Drivers and opportunities for highest revenue generating and fastest growing segments would help in tapping into specific segment to achieve growth. Moreover, regional analysis would assist in expansion strategies for the market players and startups.
The Covid-19 outbreak has severely affected every sector across the world. The patient numbers have been increasing every day and the majority of the countries are in complete lockdown. This has affected the supply chain and overall business operations. International trading has taken a significant downfall and has created uncertainty in the stock market. These factors have affected the empty capsules market.
The empty capsules report offers an in-depth analysis of the Covid-19 impact on various market segments and countries. Moreover, the report offers major market trends and forecasts, considering the Covid-19 situation.
To Get the Sample Copy of Report Visit @ https://www.alliedmarketresearch.com/request-sample/985
Capsules are the second most common form of dosage for the oral administration of drugs after tablets. These are largely used in the nutraceutical and pharmaceutical sectors. Reduction in the timelines of drug development under standard conditions has been the key factor driving the production of drugs delivered in the form of capsules among pharmaceutical and nutraceutical manufacturers. In addition, this strategy enables pharmaceutical manufacturers to reduce the time required to introduce the drug in the market. The other advantage includes protection of a drug substance from various external factors, such as natural or artificial light during production, storage, administration, and use. Furthermore, capsules act as an efficient shield, which prevents the enclosed drugs from decomposition.
Based on the product, the global empty capsules market is classified into gelatin capsules and non-gelatin capsules. Gelatin capsules are further bifurcated into hard gelatin capsules (HGCs) and soft gelatin capsules (SGCs). The gelatin segment dominated the global market in 2017 and is expected to maintain this trend throughout the forecast period. Gelatin has been the standard choice of raw material for the development of hard shell capsules that can efficiently hold active pharmaceutical ingredients (APIs). Whereas, the non-gelatin capsules segment are expected to grow at the fastest pace from 2018 to 2025. An increase in demand for hydroxypropyl methylcellulose (HPMC) capsules is the major contributor to the robust CAGR of the non-gelatin capsules segment in the global market. Furthermore, a major shift in consumer behavior has been observed toward the use of vegetarian capsules in the recent years.
For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/985
Based on therapeutic application, the market is divided into antibiotic & antibacterial drugs, vitamin & dietary supplements, antacids & anti-flatulent preparations, cardiac therapy drugs, and other applications. The antibiotic & antibacterial drugs segment dominated the global market in 2017 and is anticipated to continue this dominance throughout the forecast period. However, the vitamin & dietary supplements segment is expected to grow at the fastest pace throughout the forecast period. Consumption of antibiotics has considerably increased in the recent years. Increasing consumption of antibiotics, either prescription or over-the-counter, has resulted in incessant use of antibiotics for the treatment of ailments across the globe.
The Asia-Pacific region is expected to witness the highest growth rate throughout the forecast period, owing to its high population base, increase in disposable incomes, improvement in patient awareness toward chronic disorders, and adoption of a healthy lifestyle. In addition, countries, such as India and China, serve as major contributors to the growth of the Asia-Pacific empty capsules market, owing to the continuously evolving pharmaceutical industry in these countries.
Access Full Report @ https://www.alliedmarketresearch.com/empty-capsules-market
The Major Key Players Are:
ACG Worldwide, Bright Pharma Caps Inc., CapsCanada Corporation, Lonza Group Ltd. (Capsugel), Medi-Caps Ltd., Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.), Roxlor LLC, Snail Pharma Industry Co. Ltd, Suheung Co., Ltd, and Sunil Healthcare Ltd.
The other prominent players Are:
Patheon Ltd., Nectar Lifesciences Ltd., JC Biological Technologies, Natural Capsules Ltd., Zhejiang Huili Capsules Co., Ltd., Healthcaps India Limited, HTC Group Limited, and Nanjing Saturn Pharmaceutical Technology Co., Ltd.
Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Source: EIN Presswire